Two important therapies for ALL
What is the focus of lymphoma research in 2017?
The evolving genomic landscape of acute lymphoblastic leukemia (ALL): subtypes, genes and targets
Chemo-free approach in acute promyelocytic leukemia (APL) treatment
Francesco Lo Coco
Phase II trial of sorafenib plus standard therapy in newly diagnosed acute myeloid leukaemia